IRIS
SCANDURRA, GIUSEPPA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 313
EU - Europa 291
NA - Nord America 142
SA - Sud America 46
AF - Africa 6
OC - Oceania 1
Totale 799
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 159
IE - Irlanda 151
US - Stati Uniti d'America 138
SG - Singapore 135
IT - Italia 46
BR - Brasile 41
DE - Germania 26
GB - Regno Unito 20
FR - Francia 12
FI - Finlandia 11
AT - Austria 5
CZ - Repubblica Ceca 4
MA - Marocco 4
NL - Olanda 4
CH - Svizzera 3
BD - Bangladesh 2
BO - Bolivia 2
CN - Cina 2
IN - India 2
KG - Kirghizistan 2
LV - Lettonia 2
MX - Messico 2
TR - Turchia 2
AL - Albania 1
AZ - Azerbaigian 1
BE - Belgio 1
CA - Canada 1
CO - Colombia 1
DZ - Algeria 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
RO - Romania 1
RU - Federazione Russa 1
SE - Svezia 1
TH - Thailandia 1
TW - Taiwan 1
UA - Ucraina 1
UY - Uruguay 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 799
Salva come PNG Salva come JPEG
Città #
Hong Kong 159
Dublin 151
Boardman 50
Singapore 36
Santa Clara 21
London 13
Helsinki 10
Los Angeles 10
Milan 9
Assago 8
Palermo 7
Düsseldorf 6
Frankfurt am Main 6
São Paulo 6
The Dalles 6
Agrigento 5
Portsmouth 5
Brno 4
Seattle 4
Lauterbourg 3
Varallo Pombia 3
Zurich 3
La Paz 2
Mexico City 2
Munich 2
Riga 2
Rome 2
Tremestieri Etneo 2
Triggiano 2
Volta Redonda 2
West Jordan 2
Amman 1
Amsterdam 1
Anshan 1
Aparecida de Goiânia 1
Ariquemes 1
Auckland 1
Baku 1
Bananal 1
Bangkok 1
Barreiras 1
Belo Horizonte 1
Bishkek 1
Brussels 1
Buffalo 1
Campinas 1
Campo Grande 1
Cape Town 1
Catania 1
Cerquilho 1
Chandigarh 1
Chicago 1
Chittagong 1
Colombo 1
Cosmópolis 1
Curitiba 1
El Jadida 1
Falkenstein 1
Florence 1
Fortaleza 1
Guanhães 1
Hyvinkää 1
Ibitinga 1
Iguatu 1
Iporá 1
Itamaraju 1
Kathmandu 1
Khabarovsk 1
Kilis 1
Luxembourg 1
Medellín 1
Montevideo 1
New Haven 1
Novais 1
Novo Hamburgo 1
Nuremberg 1
Ottawa 1
Palmeira d'Oeste 1
Penápolis 1
Porto Alegre 1
Rabat 1
Resende 1
Ribeirão Preto 1
Rio das Ostras 1
Sabará 1
Salgueiro 1
Sarandi 1
Seoul 1
Simões Filho 1
Stockholm 1
Suzano 1
Tanhaçu 1
Tirana 1
Touros 1
Vienna 1
Villa 1
Viçosa 1
Totale 609
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of neoadjuvant paclitaxel, ifosfamide, and cisplatin (TIP) chemotherapy in locally advanced squamous cell cervical carcinoma followed by radical surgery: A single institution experience 47
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 44
Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma 38
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study 37
A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer 34
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 28
Pomegranate: A promising avenue against the most common chronic diseases and their associated risk factors (Review) 27
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 25
The long survival in oncology: which QoL? Finding study in more than five years after the end of treatment 25
Life Experience of Survivors of Gynecologic Cancers: A Survey Conducted in Italy 25
Homologous Recombination Deficiency (HRD) Scoring, by Means of Two Different Shallow Whole-Genome Sequencing Pipelines (sWGS), in Ovarian Cancer Patients: A Comparison with Myriad MyChoice Assay 24
Synergistic Immune-Mediated Anti-tumour Effect of Dostarlimab and Radiotherapy in the Management of MSI-H/dMMR Endometrial Cancer: A Case Report 23
The group's waiting room: groups of self-help in oncology 23
Syringoid eccrine carcinoma of the vulva: differential diagnosis, treatment, and follow-up 22
Brain Metastasis in Endometrial Cancer: A Systematic Review 18
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 18
Identification of the novel BRCA1 c.2463_2464delTA mutation in two high grade serous ovarian cancer sisters and potential dosage effects implications: a case report 16
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 16
Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy 15
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 15
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study 14
Appropriate Management of Cutaneous Adverse Events Maximizes Compliance with Sorafenib Treatment: A Single-Center Experience 13
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial 13
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome 13
Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial? 12
Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practice 12
Quality of Life in Women Diagnosed with Breast Cancer after a 12-Month Treatment of Lifestyle Modifications 12
The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes 12
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 12
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status 11
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors 11
Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study 11
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 11
Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study. 10
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma 10
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort 10
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 10
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society 10
Comprehensive Axillary Management of Clinically Node-Positive (cN+) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy 10
Correction: Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial 9
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study 9
T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer 9
Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity 9
A Survey on Knowledge and Attitudes Towards Vaccination Against Herpes Zoster Virus Among Medical Oncologists for Patients with Solid Tumors 9
Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial 8
Efficacy of trastuzumab in unselected patients with HER2-positive metastatic breast cancer: a retrospective analysis 8
Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrence ovarian cancer ( ROC) patients with BRCA 1/2 mutation. A monoistitutional experience 8
Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review) 8
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 8
Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy 8
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review) 8
Efficacy and safety of T-DM1 in the ‘common-practice’ of HER2+ advanced breast cancer setting: a multicenter study 7
De-escalation of complexity in oncoplastic breast surgery: Case series from a specialized breast center 7
The importance of planning a correct therapeutic strategy in patients with recurrent ovarian cancer. 6
Multidisciplinary team for elucidation of any new mutation and how this approach can be useful to individualize any genetic result: the case of BRCA2 c.631G>A/c.7008-2A>T genotype 6
Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention 5
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel 5
Epidermal growth factor receptor exon 20 p.S768I mutation in non-small cell lung carcinoma: A case report combined with a review of the literature and investigation of clinical significance 4
Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced or Metastatic Bladder Cancer: Long-Term Follow-Up of a 3-Week Regimen 4
Totale 882
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.461
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231 0 0 0 0 0 0 0 0 0 0 1 0
2023/2024213 1 2 13 10 24 16 34 21 14 18 26 34
2024/2025668 38 17 29 8 60 131 108 99 124 54 0 0
Totale 882